Relationship between habit of cigarette smoking and airflow limitation in healthy Japanese individuals: The Takahata study

Internal Medicine

Volumn 49, Issue 15, 2010, Pages 1489-1499

  Osaka, Daisuke ^a   Shibata, Yoko ^a   Abe, Shuichi ^a   Inoue, Sumito ^a   Tokairin, Yoshikane ^a   Igarashi, Akira ^a   Yamauchi, Keiko ^a   Kimura, Tomomi ^a   Sato, Michiko ^a   Kishi, Hiroyuki ^a   Takabatake, Noriaki ^a   Sata, Makoto ^a   Watanabe, Tetsu ^a   Konta, Tsuneo ^a   Kawata, Sumio ^a   Kato, Takeo ^a   Kubota, Isao ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Airflow limitation; Cigarette smoking; Community based health check up; COPD; Epidemiology; FEV 1; Pulmonary function test

Indexed keywords

ADULT; AGE; AGED; AIRWAY OBSTRUCTION; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; JAPAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; QUESTIONNAIRE; RISK FACTOR; SMOKING HABIT;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; COMMUNITY HEALTH SERVICES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; JAPAN; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY VENTILATION; RESPIRATORY MECHANICS; SMOKING; VITAL CAPACITY;

EID: 77956217293     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.3364     Document Type: Article

References (26)

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Revised 2006. Available at http://www.goldcopd.org/
2. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 364: 613-620, 2004.
3. Rabe KF, Beghe B, Luppi F, Fabbri LM. Update in chronic obstructive pulmonary disease 2006. Am J Respir Crit Care Med 175: 1222-1232, 2007.
4. Pierce R. Spirometry: an essential clinical measurement. Aust Fam Physician 34: 535-539, 2005.
5. Morris JF. Spirometry in the evaluation of pulmonary function. West J Med 125: 110-118, 1976.
6. Wang IM, Stepaniants S, Boie Y, et al. Gene expression profiling in patients with chronic obstructive pulmonary disease and lung cancer. Am J Respir Crit Care Med 177: 402-411, 2008.
7. Anthonisen NR, Wright EC, Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 133: 14-20, 1986.
8. Fukahori S, Matsuse H, Takamura N, et al. Prevalence of chronic obstructive pulmonary diseases in general clinics in terms of FEV1/FVC. Int J Clin Pract 63: 269-274, 2009.
9. Kamimura T, Koga T, Oshita Y, et al. Prevalence of previously undiagnosed airflow limitation in patients who underwent preoperative pulmonary function test. Kurume Med J 53: 53-57, 2006.
10. Kojima S, Sakakibara H, Motani S, et al. Effects of smoking and age on chronic obstructive pulmonary disease in Japan. J Epidemiol 15: 113-117, 2005.
11. Omori H, Nonami Y, Mihara S, Marubayashi T, Morimoto Y, Aizawa H. Prevalence of airflow limitation on medical check-up in Japanese subjects. J UOEH 29: 209-219, 2007.
12. Takemura H, Hida W, Sasaki T, Sugawara T, Sen T. Prevalence of chronic obstructive pulmonary disease in Japanese people on medical check-up. Tohoku J Exp Med 207: 41-50, 2005.
13. Tan WC, Ng TP. COPD in Asia: where East meets West. Chest 133: 517-527, 2008.
14. Fukuchi Y, Nishimura M, Ichinose M, et al. COPD in Japan: the Nippon COPD epidemiology study. Respirology 9: 458-465, 2004.
15. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J 1: 1645-1648, 1977.
16. Kohansal R, Martinez-Camblor P, Agusti A, Buist AS, Mannino DM, Soriano JB. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med 180: 3-10, 2009.
17. Kojima S, Sakakibara H, Motani S, et al. Incidence of chronic obstructive pulmonary disease, and the relationship between age and smoking in a Japanese population. J Epidemiol 17: 54-60, 2007.
18. Konta T, Hao Z, Abiko H, et al. Prevalence and risk factor analysis of microalbuminuria in Japanese general population: the Takahata study. Kidney Int 70: 751-756, 2006.
19. The Committee of Pulmonary Physiology JRS. Guidelines for pulmonary function tests: Spirometry, flow-volume curve, diffusion capacity of the lung. Tokyo, 2004 (in Japanese).
20. Pellegrino R, Brusasco V, Viegi G, et al. Definition of COPD: based on evidence or opinion? Eur Respir J 31: 681-682, 2008.
21. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 26: 948-968, 2005.
22. Cerveri I, Corsico AG, Accordini S, et al. Underestimation of airflow obstruction among young adults using FEV1/FVC <70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes. Thorax 63: 1040-1045, 2008.
23. Swanney MP, Ruppel G, Enright PL, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax 63: 1046-1051, 2008.
24. Japanese Respiratory Society. Available at http://www.jrs.or.jp/quicklink/glsm/guideline/nopass_pdf/spirogram.pdf.
25. Katanoda K, Marugame T, Saika K, et al. Population attributable fraction of mortality associated with tobacco smoking in Japan: a pooled analysis of three large-scale cohort studies. J Epidemiol 18: 251-264, 2008.
26. Ministry of Health Labour and Welfare. Measures for national health promotion. Available at http://www.mhlw.go.jp/english/wp/wp-hw2/part2/p3_0024.pdf.